8 results
Peripartum Cardiomyopathy - Summary
1. Definition
 • Towards the end of pregnancy to 5 months postpartum
Differential Diagnosis ... or dilated) • Valvular ... ancestry, LGE on MRI ... May have typical HF ... #cardiology #treatment
Severe Heart Failure & Cardiogenic Shock - Management Checklist 
Evaluation 
 - EKG & echocardiography
edema - Large effusion ... antiarrhythmics - Ischemic cardiomyopathy ... #Checklist #CHF ... #HeartFailure #Cardiology ... #Management
Heart failure with Reduced Ejection Fraction (HFrEF)
Clinical Presentation
1. Typical symptoms: dyspnea, orthopnea paroxysmal noctumal dyspnea, fatigue,
Fraction (HFrEF) Clinical ... 0.25), murmur of valvular ... bilateral pleural effusions ... heartfailure #diagnosis #management ... #cardiology #pharmacology
Amyloidosis - Summary
Group of disorders associated with extracellular deposition of fibrils formed from low-molecular-weight proteins in
Clinical suspicion ... activity of factor X, vascular ... Persistent pleural effusions ... Testing: • EKG • Echocardiogram ... enlargement • MRI
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
just simply a clinical ... #diagnosis #differential ... #algorithm #management ... #cardiology #treatment ... #heartfailure #chf
Posterior Reversible Encephalopathy Syndrome (PRES) Overview

Clinico-Radiological Syndrome, characterized by:
 • Headache
 • Seizures
 • Altered mental
brain PRES Clinical ... cortical lesions • Vascular ... narrowing on MRA ... Reversible course Differential ... Syndrome #diagnosis #management
Peripartum Cardiomyopathy (PPCM)

What is PPCM?
• A form of acute systolic heart failure that develops late in
Key Point: High clinical ... Relaxin: reduces vascular ... , selenium) Differential ... recognition and management ... #Cardiology #OBGyn
Management of Anthracyclines and HER2 Antagonist Cardiotoxicity
Anthracyclines cause cardiomyopathy:
 ✖ Reduction in left ventricular ejection fraction
Management of Anthracyclines ... receptor antagonist (MRA ... moderate to severe valvular ... dose, continuous infusion ... Cardiotoxicity #cardiology